TradingView Signals
Charting, community ideas, and alerts. Visit the official site →
Powerful tooling; signal quality belongs to the individual script or author.
What it is
TradingView is a charting and publishing platform with alerts, indicators, strategies, and community ideas. It can be an efficient research layer, but the platform is not the audited provider behind every idea published on it.
What a buyer can verify
Identify the author, read the method, distinguish backtest from live trading, inspect alert conditions, and record forward results. Public visibility does not establish a verified live record.
Who it fits
Best for self-directed traders who want flexible chart alerts.
Where the evidence stops
Community scripts can be revised, overfit, or used outside their intended regime.
Run a 30-alert forward test
Freeze the service, strategy, or scanner settings before the test begins. Log 30 consecutive qualifying alerts rather than choosing the cleanest examples. For each one, keep the original publication time, instrument, direction, entry rule, stop, target, edit history, first realistic fill after receipt, fees, slippage, close instruction, and final outcome. Mark ambiguous and missed entries instead of silently removing them.
Day-trading friction checklist
- Delivery: measure the delay between publication and receipt.
- Tradability: compare the displayed trigger with bid, ask, spread, liquidity, and halts at that moment.
- Risk: record initial stop distance, later stop changes, overlapping positions, and total open exposure.
- Accounting: include losses, cancellations, partial exits, open trades, fees, and alerts that moved before entry.
- Reconciliation: compare your complete log with any provider summary and document every excluded alert.
Questions before subscribing
Ask for the continuous dated history, the exact entry convention, the treatment of late alerts and partial fills, the maximum simultaneous exposure, and the rules for deleting or revising calls. Confirm renewal and cancellation terms before paying. A provider that cannot answer those questions has not supplied enough information for an evidence-based decision.
How this guide classifies it
We keep platform telemetry, backtests, publisher claims, and named independent evidence separate. A useful tool can still be unverified. The profile records the distinction so a buyer can decide what additional proof is needed.